Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Galiavich AS"'
Autor:
Editorial Article
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 76-77 (2013)
Externí odkaz:
https://doaj.org/article/157020b929c44cea8a4a7b6f6b3cc18d
Autor:
Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publikováno v:
Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)
Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a,
Externí odkaz:
https://doaj.org/article/749491d786994f6493162a7284467d61
Autor:
I. E. Chazova, T. V. Martynyuk, V. O. Rodnenkov, B. Sh. Gorieva, A. N. Rogoza, M. V. Arkhipov, Yu. I. Grinshtein, O. D. Ostroumova, A. S. Galiavich, O. P. Rotar’, L. A. Haisheva, T. R. Kameneva
Publikováno v:
Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)
Abstract VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter
Externí odkaz:
https://doaj.org/article/d10d2629c2744a8cb865611fbf570069
Autor:
Z M Galeeva, A S Galiavich
Publikováno v:
Терапевтический архив, Vol 86, Iss 9, Pp 71-76 (2014)
AIM. To evaluate the efficacy and safety of a fixed-dose combination of the angiotensin-converting enzyme inhibitor lisinopril 10 mg and the calcium antagonist amlodipine 5 mg (ekvator) in conjunction with rosuvastatin (mertenil). MATERIALS AND METHO
Externí odkaz:
https://doaj.org/article/b925f36a6a604e82b28ea4eb257ac73f
Autor:
A N Rogoza, Oxana Rotar, Tamila Martynyuk, Shurat B. Gorieva, Tatiana R. Kameneva, Yury I. Grinshtein, Albert S. Galiavich, Mikhail V. Arkhipov, Olga D. Ostroumova, O. V. Rodnenkov, I E Chazova, L. A. Khaisheva
Publikováno v:
Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)
Aim. Assessment of Vamloset® and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-
Autor:
L A Haisheva, A. N. Rogoza, Yu. I. Grinshtein, Olga D. Ostroumova, O. P. Rotar, A. S. Galiavich, B. Sh. Gorieva, I E Chazova, M. V. Arkhipov, T. R. Kameneva, V. O. Rodnenkov, Tamila Martynyuk
Publikováno v:
Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)
VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter prospective cli
Autor:
A S Sozinov, D I Abdulganieva, A S Galiavich, R F Khamitov, L A Khusnutdinova, T N Khalfina, N G Shamsutdinova, É R Kirillova
Publikováno v:
Терапевтический архив, Vol 86, Iss 5, Pp 120-122 (2014)
The history of the Kazan School of Therapists numbers two centuries of scientific achievements and discoveries. German Professors F.H. Erdman and K.F. Fuks laid the groundwork for clinical teaching continued by Russian therapists N.A. Skandovsky, N.A
Externí odkaz:
https://doaj.org/article/738f70c6bbb74339bd759cfd67362057
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 55-59 (2005)
Externí odkaz:
https://doaj.org/article/f1ebbd3b8d264179bcbddc4553088cb8
Publikováno v:
Kardiologiia. 49(5)
We assessed effect of antihypertensive drugs from various classes on humoral parameters of endothelial function - levels of asymmetrical dimethyl-arginine (ADMA) and metabolites of nitrous oxide (MNO) - in 106 patients with I-II degree arterial hyper
Publikováno v:
Kardiologiia. 53(7)